99% Purity Peptides Retatrutide Epithalon Tirzepatide Cagrilintide Kpv Thymosin Alpha-1 Quality Fast Delivery good price Hot Sales
TDS 1563 Inquiries
2381089-83-2
Pharmaceutical Grade
99.9%
Shanghai
DX
10mg/vial, 10vials/box
Yes
2027-08-31
GLP-1,trizepatide,Semaglutide,Retatrutide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceRetatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.Certificates-
TDS
Basic Info-
Product Name:
Retatrutide
Other Name:Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide
CAS No.:2381089-83-2
InChIKeys:MLOLQJNKXBNWFW-SAGGEDDASA-N
Molecular Weight:0
EC Number:200-001-8
Color/Form:White lyophilized
Categories:
Characteristics-
Water Solubility:
Soluble in water (5mg/ml).
Storage Conditions:-20°C
Critical Temperature & Pressure:-20°C
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
GLP-1,trizepatide,Semaglutide,Retatrutide
-
Location:
Room 2012, No. 6-143, Section 2, Shanghai Road, Guta District, Jinzhou City, Liaoning Province
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
2 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2024
-
-
Inquiry History1563 Inquiries
Country Product Purchase Quantity Date Posted
United States
Factory Retatrutide API 99% Purity CAS 2381089-83-2
5 KG Nov 10, 2025
Poland
CAS 2381089-83-2 (Custom Peptide)
40 MT Apr 10, 2026
Austria
Peptide Retatruide CAS 2381089-83-2
100 MT Apr 4, 2026
United States
GLP-1 / GIP Retatrutide cas 2381089-83-2
1 MT Oct 16, 2024
Singapore
Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service
100 MG Jun 28, 2025
Poland
Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service
5 G Feb 22, 2026
United States
Retatrutide 99% White Powder CAS 2381089-83-2 High Quality Weight Loss Peptide
10 MT Dec 16, 2025
Canada
Janoshik Test Retatrutide 10mg Weight Loss GLP-1 Injection Peptide Retatrutide 2381089-83-2 99% Puri
1 MT Nov 12, 2024
Mexico
Retatrutide
20 MG Jul 12, 2025
United Kingdom
retatrutide
40 MG Oct 11, 2025
United States
retatrutide
30 MG Nov 13, 2025
United States
Retatrutide
500 MG Apr 1, 2025
Canada
Retatrutide
120 MG Aug 4, 2025
United Kingdom
Retatrutide
500 G Apr 17, 2025
United Kingdom
Retatrutide
1 MT Dec 20, 2025
United Kingdom
Retatrutide
5 G Oct 21, 2025
United States
Retatrutide
12 MG Jan 24, 2025
India
Retatrutide
50 G Aug 29, 2025
Philippines
Retatrutide
150 G Apr 21, 2025
India
Retatrutide
1 G Jul 24, 2025 Post an enquiry for this product
More from this Seller
-
-
-
High purity over 99% Minoxidil fast delivery cas no 38304-91-5 raw material
Pharmaceutical Grade / 99%
-
-
-
-
Over 99% Purity Pharmaceutical Grade 5-amino-1mq white powder cas 42464-96-0 Raw material powder
Pharmaceutical Grade / 99.9%
-
-
-
-
Elamipretide SS-31 Peptide Powder CAS 736992-21-5 Cosmetic Raw Material
Pharmaceutical Grade / 99%
-
-
-
-
High purity over 99% igf-des raw powder fast shipping factory derect supply wholesale cas no 112603-35-7
Pharmaceutical Grade / 99%
-
-
-
-
High purity 910463-68-2 cosmetic peptide semaglutide raw lyophilized powder
Pharmaceutical Grade / 99.00%
-
-
-
-
Factory derect supply high purity over 99% snap-8 lyophilized powder package 10mg/vial
Pharmaceutical Grade / 99%
-